【制药网 行业动态】在医疗健康领域,呼吸道疾病一直是全球公共卫生面临的重大挑战之一。近期,制药企业在呼吸道疫苗市场动作频频,展现出对该领域的高度重视与大力投入。如2025 年 7 月 22 日,赛诺菲公司宣布,将以高达 16 亿美元的价格收购英国生物技术公司 Vicebio Ltd. 。根据协议,赛诺菲将预先支付 11.5 亿美元,后续若某些关键节点达成协议,还将支付高达 4.5 亿美元的额外款项...
Source Link【制药网 行业动态】在医疗健康领域,呼吸道疾病一直是全球公共卫生面临的重大挑战之一。近期,制药企业在呼吸道疫苗市场动作频频,展现出对该领域的高度重视与大力投入。如2025 年 7 月 22 日,赛诺菲公司宣布,将以高达 16 亿美元的价格收购英国生物技术公司 Vicebio Ltd. 。根据协议,赛诺菲将预先支付 11.5 亿美元,后续若某些关键节点达成协议,还将支付高达 4.5 亿美元的额外款项...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.